Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dov Pharmaceutical Inc (DOVP) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Dov Pharmaceutical Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1066833.
Total stock buying since 2005: $184,418.
Total stock sales since 2005: $19,458,545.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 1,784,829 | $48,118 | 0 | $0 | 0 | $0 |
| 2007 | 25,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2006 | 55,000 | $131,300 | 1,321,871 | $11,718,238 | 0 | $0 |
| 2005 | 0 | $0 | 456,700 | $7,740,307 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-11 | 772,327 | $2,316 | 0 | $0 | 0 | $0 |
| 2008-09 | 211,381 | $8,194 | 0 | $0 | 0 | $0 |
| 2008-08 | 200,000 | $7,000 | 0 | $0 | 0 | $0 |
| 2008-07 | 10,495 | $377 | 0 | $0 | 0 | $0 |
| 2008-06 | 76,826 | $2,765 | 0 | $0 | 0 | $0 |
| 2008-04 | 500,000 | $26,500 | 0 | $0 | 0 | $0 |
| 2008-01 | 13,800 | $966 | 0 | $0 | 0 | $0 |
| 2007-09 | 25,000 | $5,000 | 0 | $0 | 0 | $0 |
| 2006-07 | 45,000 | $104,400 | 0 | $0 | 0 | $0 |
| 2006-05 | 10,000 | $26,900 | 817,771 | $2,657,755 | 0 | $0 |
| 2006-04 | 0 | $0 | 5,000 | $80,260 | 0 | $0 |
| 2006-03 | 0 | $0 | 22,400 | $409,952 | 0 | $0 |
| 2006-02 | 0 | $0 | 466,700 | $8,411,671 | 0 | $0 |
| 2006-01 | 0 | $0 | 10,000 | $158,600 | 0 | $0 |
| 2005-11 | 0 | $0 | 200,000 | $3,040,400 | 0 | $0 |
| 2005-08 | 0 | $0 | 256,700 | $4,699,907 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-11-19 | Zakrzewski Joseph S (Director) | Buy | 772,327 | .00 | 2,316 |
| 2008-09-30 | Zakrzewski Joseph S (Director) | Buy | 125,000 | .04 | 5,000 |
| 2008-09-15 | Zakrzewski Joseph S (Director) | Buy | 16,500 | .04 | 610 |
| 2008-09-12 | Zakrzewski Joseph S (Director) | Buy | 10,000 | .04 | 370 |
| 2008-09-09 | Zakrzewski Joseph S (Director) | Buy | 1,330 | .04 | 49 |
| 2008-09-08 | Zakrzewski Joseph S (Director) | Buy | 51,500 | .04 | 1,905 |
| 2008-09-05 | Zakrzewski Joseph S (Director) | Buy | 7,051 | .04 | 260 |
| 2008-08-27 | Zakrzewski Joseph S (Director) | Buy | 200,000 | .04 | 7,000 |
| 2008-07-16 | Zakrzewski Joseph S (Director) | Buy | 10,495 | .04 | 377 |
| 2008-06-30 | Zakrzewski Joseph S (Director) | Buy | 75,826 | .04 | 2,729 |
| 2008-06-27 | Zakrzewski Joseph S (Director) | Buy | 1,000 | .04 | 36 |
| 2008-04-03 | Dov Pharmaceutical Inc (Director) | Buy | 300,000 | .05 | 15,900 |
| 2008-01-09 | Dov Pharmaceutical Inc (Director) | Buy | 13,800 | .07 | 966 |
| 2007-09-07 | Dov Pharmaceutical Inc (Director) | Buy | 25,000 | .20 | 5,000 |
| 2006-07-07 | Ashe Patrick (Director) | Buy | 45,000 | 2.32 | 104,400 |
| 2006-05-25 | Myers Scott Dunseth (Senior Vice President) | Buy | 5,000 | 2.69 | 13,450 |
| 2006-05-24 | Myers Scott Dunseth (Senior Vice President) | Buy | 5,000 | 2.69 | 13,450 |
| 2006-05-16 | Orbimed Capital Llc (Director) | Sale | 817,771 | 3.25 | 2,657,755 |
| 2006-04-03 | Skolnick Phil (Sr. V.P. Research, CSO) | Sale | 5,000 | 16.05 | 80,260 |
| 2006-03-13 | Horovitz Zola P (Director) | Sale | 12,400 | 17.43 | 216,082 |
| 2006-03-01 | Dov Pharmaceutical Inc (SVP & CSO) | Sale | 10,000 | 19.39 | 193,870 |
| 2006-02-13 | Dov Pharmaceutical Inc (SVP & CFO) | Sale | 25,000 | 19.01 | 475,250 |
| 2006-02-09 | Dov Pharmaceutical Inc (Director) | Sale | 366,700 | 18.02 | 6,613,501 |
| 2006-02-03 | Dov Pharmaceutical Inc (Director) | Sale | 20,000 | 17.12 | 342,320 |
| 2006-02-01 | Dov Pharmaceutical Inc (Director) | Sale | 5,000 | 15.82 | 79,100 |
| 2006-01-10 | Dov Pharmaceutical Inc (Director) | Sale | 10,000 | 15.86 | 158,600 |
| 2005-11-04 | Dov Pharmaceutical Inc (Director) | Sale | 200,000 | 15.20 | 3,040,400 |
| 2005-08-25 | Dov Pharmaceutical Inc (Director) | Sale | 33,300 | 18.00 | 599,400 |
| 2005-08-15 | Orbimed Capital Llc (Director) | Sale | 223,400 | 18.36 | 4,100,507 |
Insider trading activities including stock purchases, stock sales, and option exercises of DOVP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dov Pharmaceutical Inc (symbol DOVP, CIK number 1066833) see the Securities and Exchange Commission (SEC) website.